“STUDY OF THE HYPOGLYCEMIC AND CARDIOPROTECTIVE EFFECT OF EMPAGLIFLOZIN IN THERAPY OF PATIENTS WITH TYPE 2 DIABETES MELLITUS”, Wor.Bul.Pub.Helt., vol. 18, pp. 9–14, Jan. 2023, Accessed: Feb. 03, 2026. [Online]. Available: https://scholarexpress.net/index.php/wbph/article/view/1965